Drug intelligence / Profile preview

amnion + endometrium cells

Development stage
Unknown
Lead developer
Nanjing Drum-Tower Hospital
Modality
Cell Therapies
Administration
Implant, Parenteral
01

Overview

amnion + endometrium cells refers to a combination cell therapy utilizing cells derived from the amniotic membrane (typically human amniotic epithelial cells, hAECs) and the endometrium (typically endometrial mesenchymal stem cells, EnMSCs). This combination is primarily investigated for regenerative medicine applications in gynecology and reproductive health, specifically for treating premature ovarian failure (POF) and Asherman's syndrome. The therapeutic rationale is based on the synergistic effects of both cell types: amniotic cells provide potent immunomodulatory and anti-inflammatory properties, while endometrial stem cells offer high proliferative capacity and the ability to promote angiogenesis and tissue regeneration within the uterine or ovarian environment. Clinical research often involves the co-transplantation of these cells or the use of the amniotic membrane as a biological scaffold for endometrial stem cell delivery.

Other names
hAEC + EnMSChuman amniotic epithelial cells + endometrial mesenchymal stem cellsamniotic membrane + endometrial stem cellshAECs + EnMSCs

Beyond the preview

Go deeper on amnion + endometrium cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on amnion + endometrium cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call